What is the Role of Alternative Lengthening of Telomeres (ALT)?
A subset of cancers (~10-15%) maintain telomere length through the ALT pathway, which is independent of telomerase. This mechanism involves recombination-based processes that elongate telomeres. Understanding and targeting the ALT pathway is another area of active research in cancer therapy.
